Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

2001/03/01 by Biomarkers Definitions Working Group · 6,671 citations
Economics, Econometrics and Finance · Mathematics · Medicine · #Advanced Causal Inference Techniques #Citation #Computer science #Health Systems, Economic Evaluations, Quality of Life #Internal medicine #Library science #Medicine #Original research #Statistical Methods in Clinical Trials #Surrogate endpoint

paper · doi:10.1067/mcp.2001.113989

published in Clinical Pharmacology & Therapeutics 69(3), 89-95 (Wiley)

openalex publication_date 2001/03/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/04

Cited by

• Biomarker-Driven Therapeutic Management of Alzheimer’s Disease: Establishing the Foundations
• The Predictive Value of Lung Ultrasound Scores in Developing Bronchopulmonary Dysplasia
• Investigating associations between milk metabolite profiles and milk traits of Holstein cows
• Highly multiparametric analysis by mass cytometry
• The state of the art for artificial intelligence in lung digital pathology
• The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
• Republished: Value of biomarkers in osteoarthritis: current status and perspectives
• Acute Kidney Injury
• The NIMH Research Domain Criteria Initiative: Background, Issues, and Pragmatics
• Biomarkers for mitochondrial energy metabolism diseases
• ALS biomarkers for therapy development: State of the field and future directions
• The Need for Benchmarks to Advance AI-Enabled Player Risk Detection in Gambling
• Direct and Functional Biomarkers of Vitamin B6 Status
• A glossary for social-to-biological research
• Unveiling stress markers: A systematic review investigating psychological stress biomarkers
• Omega-3 and Omega-6 Fatty Acids in Blood and Breast Tissue of High-Risk Women and Association with Atypical Cytomorphology
• Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment
• Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia‐specific perspectives
• Blood Biomarkers Reflecting Brain Pathology—From Common Grounds to Rare Frontiers
• Structural abnormalities associated with poor outcome of a major depressive episode: The role of thalamus
• Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of Therapies
• Using joint models in phase I dose-finding designs in oncology: considerations for frequentist approaches
• Cholinesterases as Biomarkers for Parasympathetic Dysfunction and Inflammation-Related Disease
• Tracking biocultural pathways in population health: The value of biomarkers
• Development of imaging biomarkers and generation of big data
• EEG based Major Depressive disorder and Bipolar disorder detection using Neural Networks: A review
• Does serial procalcitonin monitoring predict clinical outcomes in children with sepsis? A diagnostic stewardship study
• A Bayesian Finite Mixture Model with Variable Selection for Data with Mixed-type Variables
• Equine Asthma: Current Understanding and Future Directions
• Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures
• Biomarkers for Psychiatric Disorders
• Are There Reliable Biomarkers for Immunosenescence and Inflammaging?
• Sex differences in the blood–brain barrier: Implications for mental health
• How quantum computing can enhance biomarker discovery
• Protease activity as a prognostic factor for wound healing in venous leg ulcers
• Realities and Expectations of Pharmacogenomics and Personalized Medicine: Impact of Translating Genetic Knowledge into Clinical Practice
• Evaluation of Optical Detection Platforms for Multiplexed Detection of Proteins and the Need for Point-of-Care Biosensors for Clinical Use
• Advances in dementia with Lewy bodies
• Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials
• Biomarker identification in bipolar disorder
• A multivariate nonlinear mixed effects model for longitudinal image analysis: Application to amyloid imaging
• Sepsis biomarkers: a review. [europepmc]
• Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy. [europepmc]
• What are biomarkers? [europepmc]
• Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. [europepmc]
• Electrochemical immunosensors for detection of cancer protein biomarkers. [europepmc]
• Alarmins: awaiting a clinical response. [europepmc]
• Parkinson's disease. [europepmc]
• Marital quality and health: a meta-analytic review. [europepmc]
• Translational biomarker discovery in clinical metabolomics: an introductory tutorial. [europepmc]
• Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment. [europepmc]
• HMGB1 in health and disease. [europepmc]
• Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. [europepmc]
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. [europepmc]
• Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. [europepmc]
• Risk factors and biomarkers of age-related macular degeneration. [europepmc]
• Imaging biomarker roadmap for cancer studies. [europepmc]
• The new field of 'precision psychiatry'. [europepmc]
• Sepsis: A Review of Advances in Management. [europepmc]
• Inflammatory biomarkers of low back pain and disc degeneration: a review. [europepmc]
• Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. [europepmc]
• Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. [europepmc]
• Biomarkers of sepsis: time for a reappraisal. [europepmc]
• Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities. [europepmc]
• HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer. [europepmc]
• Biomarkers for the diagnosis and management of heart failure. [europepmc]